{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T21:48:36Z","timestamp":1792619316972,"version":"4.5.0"},"reference-count":78,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T00:00:00Z","timestamp":1622592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Histone deacetylase inhibitors (HDACIs) are antitumor drugs that are being developed for use in clinical settings. HDACIs enhance histone or nonhistone acetylation and promote gene transcription <jats:italic>via<\/jats:italic> epigenetic regulation. Importantly, these drugs have cytotoxic or cytostatic properties and can directly inhibit tumor cells. However, how HDACIs regulate immunocytes in the tumor microenvironment, such as myeloid-derived suppressor cells (MDSCs), has yet to be elucidated. In this review, we summarize the effects of different HDACIs on the immunosuppressive function and expansion of MDSCs based on the findings of relevant studies.<\/jats:p>","DOI":"10.3389\/fimmu.2021.690207","type":"journal-article","created":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T14:16:10Z","timestamp":1622643370000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":26,"title":["Regulatory Effects of Histone Deacetylase Inhibitors on Myeloid-Derived Suppressor Cells"],"prefix":"10.3389","volume":"12","author":[{"given":"Yudan","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingshan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-2584","article-title":"SIRT1 Limits the Function and Fate of Myeloid-Derived Suppressor Cells in Tumors by Orchestrating HIF-1alpha-dependent Glycolysis","volume":"74","author":"Liu","year":"2014","journal-title":"Cancer Res"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201041170","article-title":"The Growing Diversity and Spectrum of Action of Myeloid-Derived Suppressor Cells","volume":"40","author":"Mantovani","year":"2010","journal-title":"Eur J Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-017-0022-x","article-title":"Myeloid-Derived Suppressor Cells Coming of Age","volume":"19","author":"Veglia","year":"2018","journal-title":"Nat Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-Associated Macrophages as Treatment Targets in Oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for Myeloid-Derived Suppressor Cell Nomenclature and Characterization Standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat Commun"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.4RI0515-204R","article-title":"Transcriptional Regulation of Myeloid-Derived Suppressor Cells","volume":"98","author":"Condamine","year":"2015","journal-title":"J Leukoc Biol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41577-020-00490-y","article-title":"Myeloid-Derived Suppressor Cells in the Era of Increasing Myeloid Cell Diversity","volume":"1","author":"Veglia","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1158\/2326-6066.CIR-16-0297","article-title":"Myeloid-Derived Suppressor Cells","volume":"5","author":"Gabrilovich","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1800695115","article-title":"Myeloid-Derived Suppressor Cells Inhibit T Cell Activation Through Nitrating LCK in Mouse Cancers","volume":"115","author":"Feng","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/s1471-4906(03)00132-7","article-title":"L-Arginine Metabolism in Myeloid Cells Controls T-Lymphocyte Functions","volume":"24","author":"Bronte","year":"2003","journal-title":"Trends Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2016.10.003","article-title":"Immunosuppressive Myeloid Cells\u2019 Blockade in the Glioma Microenvironment Enhances the Efficacy of Immune-Stimulatory Gene Therapy","volume":"25","author":"Kamran","year":"2017","journal-title":"Mol Ther"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/nri3175","article-title":"Coordinated Regulation of Myeloid Cells by Tumours","volume":"12","author":"Gabrilovich","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-03-634691","article-title":"GVHD-Associated, Inflammasome-Mediated Loss of Function in Adoptively Transferred Myeloid-Derived Suppressor Cells","volume":"126","author":"Koehn","year":"2015","journal-title":"Blood"},{"key":"B14","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.immuni.2010.05.010","article-title":"Tumor-Induced Tolerance and Immune Suppression Depend on the C\/EBPbeta Transcription Factor","volume":"32","author":"Marigo","year":"2010","journal-title":"Immunity"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v18.i25.3303","article-title":"Increased Frequency and Clinical Significance of Myeloid-Derived Suppressor Cells in Human Colorectal Carcinoma","volume":"18","author":"Sun","year":"2012","journal-title":"World J Gastroenterol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0057114","article-title":"Circulating and Tumor-Infiltrating Myeloid-Derived Suppressor Cells in Patients With Colorectal Carcinoma","volume":"8","author":"Zhang","year":"2013","journal-title":"PloS One"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/advs.201901278","article-title":"Granulocytic Myeloid-Derived Suppressor Cells Promote the Stemness of Colorectal Cancer Cells Through Exosomal S100A9","volume":"6","author":"Wang","year":"2019","journal-title":"Adv Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00262-008-0523-4","article-title":"Increased Circulating Myeloid-Derived Suppressor Cells Correlate With Clinical Cancer Stage, Metastatic Tumor Burden, and Doxorubicin-Cyclophosphamide Chemotherapy","volume":"58","author":"Diaz-Montero","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2015.0289","article-title":"Circulating Myeloid-Derived Suppressor Cells Predict Differentiated Thyroid Cancer Diagnosis and Extent","volume":"26","author":"Angell","year":"2016","journal-title":"Thyroid"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00473","article-title":"Long Non-Coding RNA HOXA Transcript Antisense RNA Myeloid-Specific 1-HOXA1 Axis Downregulates the Immunosuppressive Activity of Myeloid-Derived Suppressor Cells in Lung Cancer","volume":"9","author":"Tian","year":"2018","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-013-1450-6","article-title":"Increased CD14(+)HLA-DR (-\/Low) Myeloid-Derived Suppressor Cells Correlate With Extrathoracic Metastasis and Poor Response to Chemotherapy in Non-Small Cell Lung Cancer Patients","volume":"62","author":"Huang","year":"2013","journal-title":"Cancer Immunol Immunother"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-013-1475-x","article-title":"Myeloid-Derived Suppressor Cells are Associated With Disease Progression and Decreased Overall Survival in Advanced-Stage Melanoma Patients","volume":"62","author":"Jordan","year":"2013","journal-title":"Cancer Immunol Immunother"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.15456","article-title":"Neutrophil Count is Associated With Myeloid Derived Suppressor Cell Level and Presents Prognostic Value of for Hepatocellular Carcinoma Patients","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-014-1646-4","article-title":"Tumor-Induced CD14+HLA-DR (-\/Low) Myeloid-Derived Suppressor Cells Correlate With Tumor Progression and Outcome of Therapy in Multiple Myeloma Patients","volume":"64","author":"Wang","year":"2015","journal-title":"Cancer Immunol Immunother"},{"key":"B25","article-title":"Prognostic Significance of Peripheral Monocytic Myeloid-Derived Suppressor Cells and Monocytes in Patients Newly Diagnosed With Diffuse Large B-Cell Lymphoma","volume":"8","author":"Wu","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.8507","article-title":"Identification of Granulocytic Myeloid-Derived Suppressor Cells (G-MDSCs) in the Peripheral Blood of Hodgkin and Non-Hodgkin Lymphoma Patients","volume":"7","author":"Marini","year":"2016","journal-title":"Oncotarget"},{"key":"B27","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.semcancer","article-title":"Combining Epigenetic and Immune Therapy to Overcome Cancer Resistance","volume":"65","author":"Gomez","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1712514114","article-title":"Epigenetic Therapy Activates Type I Interferon Signaling in Murine Ovarian Cancer to Reduce Immunosuppression and Tumor Burden","volume":"114","author":"Stone","year":"2017","journal-title":"Proc Natl Acad Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed","article-title":"The Role of Vitamin C in Epigenetic Cancer Therapy","author":"Mikkelsen","year":"2021","journal-title":"Free Radic Biol Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c02255","article-title":"In Vivo Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a With Efficacy in Multiple Myeloma","volume":"64","author":"Rabal","year":"2021","journal-title":"J Med Chem"},{"key":"B31","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/icb.2011.100","article-title":"HDAC Inhibitors in Cancer Biology: Emerging Mechanisms and Clinical Applications","volume":"90","author":"Khan","year":"2012","journal-title":"Immunol Cell Biol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2021.188522","article-title":"The Role of N6-Methyladenosine mRNA in the Tumor Microenvironment","volume":"1875","author":"Li","year":"2021","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-18-0070","article-title":"Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers Into Checkpoint-Responsive Tumors by Reprogramming Tumor-Infiltrating Mdscs","volume":"6","author":"Christmas","year":"2018","journal-title":"Cancer Immunol Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2054-x","article-title":"Epigenetic Therapy Inhibits Metastases by Disrupting Premetastatic Niches","volume":"579","author":"Lu","year":"2020","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphs.2018.06.014","article-title":"Valproic Acid Attenuates Immunosuppressive Function of Myeloid-Derived Suppressor Cells","volume":"137","author":"Xie","year":"2018","journal-title":"J Pharmacol Sci"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2020.1734268","article-title":"Valproic Acid Attenuates CCR2-Dependent Tumor Infiltration of Monocytic Myeloid-Derived Suppressor Cells, Limiting Tumor Progression","volume":"9","author":"Xie","year":"2020","journal-title":"Oncoimmunology"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-017-2091-y","article-title":"The Class I\/IV HDAC Inhibitor Mocetinostat Increases Tumor Antigen Presentation, Decreases Immune Suppressive Cell Types and Augments Checkpoint Inhibitor Therapy","volume":"67","author":"Briere","year":"2017","journal-title":"Cancer Immunol Immunotherapy"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-016-1935-1","article-title":"Histone Deacetylase Inhibitors Deplete Myeloid-Derived Suppressor Cells Induced by 4T1 Mammary Tumors In Vivo and In Vitro","volume":"66","author":"Wang","year":"2017","journal-title":"Cancer Immunol Immunother"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0311119","article-title":"Histone Deacetylase Inhibition Facilitates GM-CSF-Mediated Expansion of Myeloid-Derived Suppressor Cells In Vitro and In Vivo","volume":"91","author":"Rosborough","year":"2012","journal-title":"J Leukoc Biol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.7150\/jca.44622","article-title":"Hdac Inhibitor, Cg-745, Enhances the Anti-Cancer Effect of Anti-PD-1 Immune Checkpoint Inhibitor by Modulation of the Immune Microenvironment","volume":"11","author":"Kim","year":"2020","journal-title":"J Cancer"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0062-8","article-title":"Histone Deacetylase (HDAC) Inhibitor ACY241 Enhances Anti-Tumor Activities of Antigen-Specific Central Memory Cytotoxic T Lymphocytes Against Multiple Myeloma and Solid Tumors","volume":"32","author":"Bae","year":"2018","journal-title":"Leukemia"},{"key":"B42","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.expneurol.2018.02.008","article-title":"Amelioration of Progressive Autoimmune Encephalomyelitis by Epigenetic Regulation Involves Selective Repression of Mature Neutrophils During the Preclinical Phase","volume":"304","author":"Jayaraman","year":"2018","journal-title":"Exp Neurol"},{"key":"B43","doi-asserted-by":"crossref","DOI":"10.1016\/S0021-9258(17)33793-6","article-title":"Evidence That Approximately Eighty Per Cent of the Soluble Proteins From Ehrlich Ascites Cells Are Nalpha-Acetylated","volume":"251","author":"Brown","year":"1976","journal-title":"J Biol Chem"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0901931106","article-title":"Proteomics Analyses Reveal the Evolutionary Conservation and Divergence of N-terminal Acetyltransferases From Yeast and Humans","volume":"106","author":"Arnesen","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.01.053","article-title":"An Organellar N\u03b1-Acetyltransferase, naa60, Acetylates Cytosolic N Termini of Transmembrane Proteins and Maintains Golgi Integrity","volume":"10","author":"Aksnes","year":"2015","journal-title":"Cell Rep"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.51.5.786","article-title":"Acetylation and Methylation of Histones and Their Possible Role in the Regulation of RNA Synthesis","volume":"51","author":"Allfrey","year":"1964","journal-title":"Proc Natl Acad Sci USA"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-018-0081-3","article-title":"Functions and Mechanisms of non-Histone Protein Acetylation","volume":"20","author":"Narita","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-020-03599-4","article-title":"Regulation of Histone Deacetylase Activities and Functions by Phosphorylation and Its Physiological Relevance","volume":"78","author":"Bahl","year":"2020","journal-title":"Cell Mol Life Sci CMLS"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.43140","article-title":"The Role of Histone Acetyltransferases and Histone Deacetylases in Photoreceptor Differentiation and Degeneration","volume":"17","author":"Zhao","year":"2020","journal-title":"Int J Med Sci"},{"key":"B50","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.gene.2005.09.010","article-title":"Acetylation and Deacetylation of Non-Histone Proteins","volume":"363","author":"Glozak","year":"2005","journal-title":"Gene"},{"key":"B51","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/ni.1673","article-title":"The Histone Deacetylase HDAC11 Regulates the Expression of Interleukin 10 and Immune Tolerance","volume":"10","author":"Villagra","year":"2009","journal-title":"Nat Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrc1779","article-title":"Histone Deacetylase Inhibitors and the Promise of Epigenetic (and More) Treatments for Cancer","volume":"6","author":"Minucci","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.2217\/epi.15.118","article-title":"Histone Deacetylase Inhibitors as Immunomodulators in Cancer Therapeutics","volume":"8","author":"Shen","year":"2016","journal-title":"Epigenomics"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1007\/s13148-010-0012-4","article-title":"Histone Deacetylase (HDAC) Inhibitors in Recent Clinical Trials for Cancer Therapy","volume":"1","author":"Wagner","year":"2010","journal-title":"Clin Epigenet"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3390\/ph3092751","article-title":"Clinical Toxicities of Histone Deacetylase Inhibitors","volume":"3","author":"Subramanian","year":"2010","journal-title":"Pharmaceuticals (Basel Switzerland)"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-07-0014","article-title":"Synergistic In Vivo Antitumor Effect of the Histone Deacetylase Inhibitor MS-275 in Combination With Interleukin 2 in a Murine Model of Renal Cell Carcinoma","volume":"13","author":"Kato","year":"2007","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030815","article-title":"Class I Histone Deacetylase Inhibitor Entinostat Suppresses Regulatory T Cells and Enhances Immunotherapies in Renal and Prostate Cancer Models","volume":"7","author":"Shen","year":"2012","journal-title":"PloS One"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1011037108","article-title":"Eradication of Solid Tumors Using Histone Deacetylase Inhibitors Combined With Immune-Stimulating Antibodies","volume":"108","author":"Christiansen","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"B59","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/TA.0000000000000896","article-title":"Histone Deactylase Gene Expression Profiles Are Associated With Outcomes in Blunt Trauma Patients","volume":"80","author":"Sillesen","year":"2016","journal-title":"J Trauma Acute Care Surg"},{"key":"B60","article-title":"Histone Deacetylase Inhibitors: Molecular Mechanisms of Action and Clinical Trials as Anti-Cancer Drugs","volume":"3","author":"Kim","year":"2011","journal-title":"Am J Trans Res"},{"key":"B61","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40360-019-0294-x","article-title":"Histone Deacetylase Inhibition by Entinostat for the Prevention of Electrical and Structural Remodeling in Heart Failure","volume":"20","author":"Freundt","year":"2019","journal-title":"BMC Pharmacol Toxicol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-0741","article-title":"Entinostat Neutralizes Myeloid-Derived Suppressor Cells and Enhances the Antitumor Effect of PD-1 Inhibition in Murine Models of Lung and Renal Cell Carcinoma","volume":"23","author":"Orillion","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2017.1353077","article-title":"Entinostat for the Treatment of Breast Cancer","volume":"26","author":"Trapani","year":"2017","journal-title":"Expert Opin Invest Drugs"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2015.1056779","article-title":"Entinostat (SNDX-275) for the Treatment of non-Small Cell Lung Cancer","volume":"24","author":"Ruiz","year":"2015","journal-title":"Expert Opin Invest Drugs"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2016.1219008","article-title":"The Interplay of Epigenetic Therapy and Immunity in Locally Recurrent or Metastatic Estrogen Receptor-Positive Breast Cancer: Correlative Analysis of ENCORE 301, A Randomized, Placebo-Controlled Phase II Trial of Exemestane With or Without Entinostat","volume":"5","author":"Tomita","year":"2016","journal-title":"Oncoimmunology"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-020-02588-7","article-title":"Selective Targeting of Different Populations of Myeloid-Derived Suppressor Cells by Histone Deacetylase Inhibitors","volume":"69","author":"Hashimoto","year":"2020","journal-title":"Cancer Immunol Immunother"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/nature10138","article-title":"CCL2 Recruits Inflammatory Monocytes to Facilitate Breast-Tumour Metastasis","volume":"475","author":"Qian","year":"2011","journal-title":"Nature"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/nature13862","article-title":"Cessation of CCL2 Inhibition Accelerates Breast Cancer Metastasis by Promoting Angiogenesis","volume":"515","author":"Bonapace","year":"2014","journal-title":"Nature"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2007.11.003","article-title":"Valproic Acid as Epigenetic Cancer Drug: Preclinical, Clinical and Transcriptional Effects on Solid Tumors","volume":"34","author":"Duenas-Gonzalez","year":"2008","journal-title":"Cancer Treat Rev"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic Acid Defines a Novel Class of HDAC Inhibitors Inducing Differentiation of Transformed Cells","volume":"20","author":"G\u00f6ttlicher","year":"2001","journal-title":"EMBO J"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-03-0799","article-title":"Histone Deacetylase Is a Target of Valproic Acid-Mediated Cellular Differentiation","volume":"64","author":"Gurvich","year":"2004","journal-title":"Cancer Res"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2019.11.155","article-title":"Blockade of Myeloid-Derived Suppressor Cell Function by Valproic Acid Enhanced anti-PD-L1 Tumor Immunotherapy","volume":"522","author":"Adeshakin","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2133","article-title":"Anticancer Activities of Histone Deacetylase Inhibitors","volume":"5","author":"Bolden","year":"2006","journal-title":"Nat Rev Drug Discovery"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2065","article-title":"Histone Deacetylase Inhibitor-Temozolomide Co-Treatment Inhibits Melanoma Growth Through Suppression of Chemokine (C-C Motif) Ligand 2-Driven Signals","volume":"5","author":"Gatti","year":"2014","journal-title":"Oncotarget"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2016.1164919","article-title":"Anti-GD2 mAb and Vorinostat Synergize in the Treatment of Neuroblastoma","volume":"5","author":"Kroesen","year":"2016","journal-title":"Oncoimmunology"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903830","article-title":"Histone Acetylation At the Single-Cell Level: A Marker of Memory CD8+ T Cell Differentiation and Functionality","volume":"184","author":"Dispirito","year":"2010","journal-title":"J Immunol (Baltimore Md 1950)"},{"key":"B77","doi-asserted-by":"publisher","first-page":"5966","DOI":"10.3390\/ijms21175966","article-title":"Trichostatin A Alleviates Renal Interstitial Fibrosis Through Modulation of the M2 Macrophage Subpopulation","volume":"21","author":"Tseng","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.17388","article-title":"Trans-Scirpusin A Showed Antitumor Effects Via Autophagy Activation and Apoptosis Induction of Colorectal Cancer Cells","volume":"8","author":"Hong","year":"2017","journal-title":"Oncotarget"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.690207\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T14:16:14Z","timestamp":1622643374000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.690207\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,2]]},"references-count":78,"alternative-id":["10.3389\/fimmu.2021.690207"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.690207","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,2]]},"article-number":"690207"}}